Skip to main content
OpenTrials
Completed

NCT Number: NCT03177759

Living With Prostate Cancer (LPC)

This is a prospective evaluation to determine the effectiveness of the Prostate Cancer Supportive Care (PCSC) Program's group therapy program, Living with Prostate Cancer (LPC). LPC is an intervention which utilizes a small group format (5-7 participants with 2 leaders and a paraprofessional counselling student) to understand and learn how to manage emotional responses, depressive symptoms, and life stressors associated with prostate cancer. Data for this evaluation will be derived from a focus group (at 3 months) and self-report questionnaires that participants will complete immediately prior to the intervention, immediately following the intervention and at 3, 6, and 12-months post-intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Vancouver Prostate Centre

Vancouver, British Columbia, V5Z 1M9, Canada

About this study

The Vancouver Prostate Centre's (VPCs) PCSC Program is designed to address the gap in supportive care for men with prostate cancer (PC), their partners and their families. The evaluation protocol described here is specific to the program called "Living with Prostate Cancer" (LPC) from the Psychooncology module of the PCSC Program. The specific rationale for this module is that many cancer patients will experience significant anxiety or depression at some point along their cancer journey. The module includes private, confidential clinic appointments for PC patients and their spouses/partners, either separately or together, with our registered clinical counsellor, to explore how to cope with difficult emotions such as fear, anxiety, sadness, helplessness, and other signs of emotional distress. The module is now being expanded to include small group discussions. LPC is a group therapy program in which men participate in a guided autobiographical life review through a process that focuses on developing a cohesive working group, learning strategic communication skills, and understanding and learning how to manage difficult emotions and transitional life stressors associated with PC. It also focuses on the processing and integrating of critical events that contribute to the men's present day identity and psychological function and involves the consolidation of the personal learning that occurs. It shifts the focus on transitioning into the future by developing specific individual, family and/or career goals that are reinforced by ongoing support from peers in the group. Finally, post-group referral plans are developed on an individual basis as needed.

The group therapy program includes men with a diagnosis of PC Stages 1 to 3. We will administer validated quantitative tools to assess depression and anxiety, general psychological functioning, and male role norms (masculinity) before, after, and at 3, 6, and 12-months following the program. The meeting 3 months after the program will include a focus group process.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men are eligible to participate in this evaluation if they:

  • are older than 18 years old
  • are willing to attend the "Living with Prostate Cancer" group therapy sessions from the PCSC Program*
  • are able to speak and read English such that they are able to understand the questionnaires
  • have unimpaired cognitive function with an ability to understand the nature of the study
  • are willing to complete questionnaires at 5 time points
  • provide written informed consent
  • to be able to participate in LPC groups, men must have recently received a diagnosis of PC Stages 1 to 3, or have recently been recommended to undergo a form of treatment following a period of active surveillance.

Exclusion criteria

Men will be ineligible to participate in this evaluation if they:

  • have difficulties reading or understanding English
  • have psychotic symptoms, current severe alcohol or other drug dependence, unwillingness to refrain from substance use during the program, and/or significant cognitive impairment that would prevent them participating or providing full informed consent.

Treatment and study plan

Primary outcomes

  1. Changes in depressive and anxiety symptoms

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

    Measured by the Beck Depression Inventory

Secondary outcomes

  1. Changes in overall well-being

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

    Measured by the Warwick-Edinburgh Mental Wellbeing Scale

  2. Changes in perceptions of masculinity

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

    Measured by the Personal Attributes Questionnaire

  3. Changes in perceptions of masculinity

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

    Measured by the Masculine Behaviour Scale

  4. Group cohesion and dynamics

    Time frame: 3-Weeks (Post-workshop), 3-, 6- and 12 Months

    Measured by the Group Questionnaire

  5. Patient-incurred costs for attending the session

    Time frame: 3-Weeks (Post-Workshop)

    Measured by an annotated cost questionnaire for completion by patients

Sponsors and collaborators

Lead sponsor

Vancouver Prostate Centre

Other

Registry information

Official study title

Evaluating a Group Therapy Intervention to Alleviate Psychological Distress in Men With Prostate Cancer: An Assessment of a Group Therapy Program From Vancouver's Prostate Cancer Supportive Care (PCSC) Program

Acronym: LPC

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Jun 6, 2017
Registry last updated
Oct 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.